We are proud to announce that we have successfully integrated 120 cases in the clinical study of Alexandria site. The initial trial launched in December 2019 at the Alexandria University, Egypt with Principal Investigators: Prof. Ahmed Elmassry and Prof. Osama Ibrahim and with the objective to perform the fixOflex implantation and 12-month follow up in 120 patients.